发明名称 |
Modified biotin-binding protein, fusion proteins thereof and applications |
摘要 |
The disclosure provides modified biotin-binding proteins which can be expressed in soluble form in high yield in bacteria. Also provided are fusion proteins comprising the modified biotin-binding protein and an antigen. The disclosure further provides non-hemolytic variants of alpha-hemolysin from S. aureus and fusion protein comprising non-hemolytic variant of alpha-hemolysin and a biotin-binding domains. Immunogenic compositions comprising the proteins are also disclosed and use of such immunogenic compositions for inducing an immune response or for vaccinating a subject are also disclosed. |
申请公布号 |
US9499593(B2) |
申请公布日期 |
2016.11.22 |
申请号 |
US201214116492 |
申请日期 |
2012.05.11 |
申请人 |
Children's Medical Center Corporation |
发明人 |
Malley Richard;Lu Yingjie;Zhang Fan |
分类号 |
A61K39/00;A61K39/02;C07K14/31;A61K47/48 |
主分类号 |
A61K39/00 |
代理机构 |
Nixon Peabody LLP |
代理人 |
Nixon Peabody LLP |
主权项 |
1. A vaccine composition comprising a soluble biotin-binding protein consisting essentially of an amino acid sequence having at least 85% sequence identity to SEQ ID NO: 1, wherein the biotin-binding protein has a higher solubility than the biotin-binding protein of SEQ ID NO: 4. |
地址 |
Boston MA US |